TFPI c.359-1349A>T

Variant ID: 2-188351063-T-A

NM_006287.4(TFPI):c.359-1349A>T

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.

Breast Cancer Research : Bcr
Tinholt, Mari M; Vollan, Hans Kristian Moen HK; Sahlberg, Kristine Kleivi KK; Jernström, Sandra S; Kaveh, Fatemeh F; Lingjærde, Ole Christian OC; Kåresen, Rolf R; Sauer, Torill T; Kristensen, Vessela V; Børresen-Dale, Anne-Lise AL; Sandset, Per Morten PM; Iversen, Nina N
Publication Date: 2015-03-26

Variant appearance in text: rs8176508
PubMed Link: 25882602
Variant Present in the following documents:
  • Main text
  • 13058_2015_Article_548.pdf
View BVdb publication page



Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.

Plos One
Ryckman, Kelli K KK; Morken, Nils-Halvdan NH; White, Marquitta J MJ; Velez, Digna R DR; Menon, Ramkumar R; Fortunato, Stephen J SJ; Magnus, Per P; Williams, Scott M SM; Jacobsson, Bo B
Publication Date: 2010-02-03

Variant appearance in text: rs8176508
PubMed Link: 20140262
Variant Present in the following documents:
  • Main text
  • pone.0009040.pdf
View BVdb publication page